286 related articles for article (PubMed ID: 24609063)
1. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States.
Clements KM; Meier G; McGarry LJ; Pruttivarasin N; Misurski DA
Hum Vaccin Immunother; 2014; 10(5):1171-80. PubMed ID: 24609063
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
Brogan AJ; Talbird SE; Davis AE; Thommes EW; Meier G
Hum Vaccin Immunother; 2017 Mar; 13(3):533-542. PubMed ID: 27780425
[TBL] [Abstract][Full Text] [Related]
3. An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model.
Chit A; Roiz J; Aballea S
PLoS One; 2015; 10(7):e0133606. PubMed ID: 26222538
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults.
Raviotta JM; Smith KJ; DePasse J; Brown ST; Shim E; Nowalk MP; Zimmerman RK
J Am Geriatr Soc; 2016 Oct; 64(10):2126-2131. PubMed ID: 27709600
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.
Raviotta JM; Smith KJ; DePasse J; Brown ST; Shim E; Nowalk MP; Wateska A; France GS; Zimmerman RK
Vaccine; 2017 Oct; 35(42):5708-5713. PubMed ID: 28890196
[TBL] [Abstract][Full Text] [Related]
6. Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors.
Chit A; Roiz J; Briquet B; Greenberg DP
Vaccine; 2015 Jan; 33(5):734-41. PubMed ID: 25444791
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017.
Gaglani M; Vasudevan A; Raiyani C; Murthy K; Chen W; Reis M; Belongia EA; McLean HQ; Jackson ML; Jackson LA; Zimmerman RK; Nowalk MP; Monto AS; Martin ET; Chung JR; Spencer S; Fry AM; Flannery B
Clin Infect Dis; 2021 Apr; 72(7):1147-1157. PubMed ID: 32006430
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
Yang MC; Tan EC; Su JJ
Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy.
Mennini FS; Bini C; Marcellusi A; Rinaldi A; Franco E
Hum Vaccin Immunother; 2018; 14(8):1867-1873. PubMed ID: 29708843
[TBL] [Abstract][Full Text] [Related]
10. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
[TBL] [Abstract][Full Text] [Related]
11. [Technical guidelines for seasonal influenza vaccination in China (2023-2024)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct; 44(10):1507-1530. PubMed ID: 37875437
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study.
Treanor JT; Albano FR; Sawlwin DC; Graves Jones A; Airey J; Formica N; Matassa V; Leong J
Vaccine; 2017 Apr; 35(15):1856-1864. PubMed ID: 28302411
[TBL] [Abstract][Full Text] [Related]
13. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.
Grohskopf LA; Sokolow LZ; Broder KR; Walter EB; Fry AM; Jernigan DB
MMWR Recomm Rep; 2018 Aug; 67(3):1-20. PubMed ID: 30141464
[TBL] [Abstract][Full Text] [Related]
14. Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons.
Boikos C; Fischer L; O'Brien D; Vasey J; Sylvester GC; Mansi JA
Clin Infect Dis; 2021 Sep; 73(5):816-823. PubMed ID: 33605977
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland.
Nagy L; Heikkinen T; Sackeyfio A; Pitman R
Pharmacoeconomics; 2016 Sep; 34(9):939-51. PubMed ID: 27423657
[TBL] [Abstract][Full Text] [Related]
16. Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial.
Sesay S; Brzostek J; Meyer I; Donazzolo Y; Leroux-Roels G; Rouzier R; Astruc B; Szymanski H; Toursarkissian N; Vandermeulen C; Kowalska E; Van Damme P; Salamand C; Pepin S
Hum Vaccin Immunother; 2018 Mar; 14(3):596-608. PubMed ID: 28968138
[TBL] [Abstract][Full Text] [Related]
17. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
[TBL] [Abstract][Full Text] [Related]
18. Assessment of potential public health impact of a quadrivalent inactivated influenza vaccine in Thailand.
Kittikraisak W; Chittaganpitch M; Gregory CJ; Laosiritaworn Y; Thantithaveewat T; Dawood FS; Lindblade KA
Influenza Other Respir Viruses; 2016 May; 10(3):211-9. PubMed ID: 26588892
[TBL] [Abstract][Full Text] [Related]
19. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.
Grohskopf LA; Sokolow LZ; Broder KR; Walter EB; Bresee JS; Fry AM; Jernigan DB
MMWR Recomm Rep; 2017 Aug; 66(2):1-20. PubMed ID: 28841201
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
Gorse GJ; Falsey AR; Ozol-Godfrey A; Landolfi V; Tsang PH
Vaccine; 2015 Feb; 33(9):1151-9. PubMed ID: 25613721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
